Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Garrison

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Public Health Genomics|February 11, 2009
Will pharmacogenomics disrupt the U.S. health care system? NoL P Garrison
Atlanta Medical and Surgical Journal|July 13, 2022
Placenta PræviaL P Garrison
Health Care Financing Review. Annual Supplement|December 10, 1990
Assessment of the effectiveness of supply-side cost-containment measuresL P Garrison
Health Care Financing Review|November 5, 1990
Medicaid, the uninsured, and national health spending: federal policy implicationsL P Garrison
Health Affairs (Project Hope)|January 1, 1986
Cost containment and incentives for technologyL P Garrison, G R Wilensky
Radiology|April 1, 1984
The supply of and requirements for diagnostic and therapeutic radiologistsJ Wills, L P Garrison, R G Evens
Vaccine|May 5, 2009
Scheduling of measles vaccination in low-income countries: projections of a dynamic modelC T Bauch, E Szusz, L P Garrison
Health Policy (Amsterdam, Netherlands)|July 25, 2019
Challenges in the value assessment, pricing and funding of targeted combination therapies in oncologyD Dankó, J-Y Blay, L P Garrison
Ophthalmology|November 1, 1981
Manpower requirements in ophthalmologyJ Wills, L P Garrison, M L Peterson
Journal of the American Society of Nephrology : JASN|October 23, 1997
The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study GroupS D Sullivan, L P Garrison, J H Best
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Public Health Genomics|February 11, 2009
Will pharmacogenomics disrupt the U.S. health care system? NoL P Garrison
Atlanta Medical and Surgical Journal|July 13, 2022
Placenta PræviaL P Garrison
Health Care Financing Review. Annual Supplement|December 10, 1990
Assessment of the effectiveness of supply-side cost-containment measuresL P Garrison
Health Care Financing Review|November 5, 1990
Medicaid, the uninsured, and national health spending: federal policy implicationsL P Garrison
Health Affairs (Project Hope)|January 1, 1986
Cost containment and incentives for technologyL P Garrison, G R Wilensky
Radiology|April 1, 1984
The supply of and requirements for diagnostic and therapeutic radiologistsJ Wills, L P Garrison, R G Evens
Vaccine|May 5, 2009
Scheduling of measles vaccination in low-income countries: projections of a dynamic modelC T Bauch, E Szusz, L P Garrison
Health Policy (Amsterdam, Netherlands)|July 25, 2019
Challenges in the value assessment, pricing and funding of targeted combination therapies in oncologyD Dankó, J-Y Blay, L P Garrison
Ophthalmology|November 1, 1981
Manpower requirements in ophthalmologyJ Wills, L P Garrison, M L Peterson
Journal of the American Society of Nephrology : JASN|October 23, 1997
The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study GroupS D Sullivan, L P Garrison, J H Best
Pageof 3